| Trial Name: |
Posttraumatic Stress Disorder (PTSD), Adults
|
| Intro: |
This research study is designed to compare two treatments for posttraumatic stress disorder (PTSD) in adults: exposure therapy, a cognitive-behavioral talk therapy, and Zoloft (or sertraline), an antidepressant medication. |
| Condition: |
|
| Description: |
This research study is designed to compare two treatments for posttraumatic stress disorder (PTSD) in adults: exposure therapy, a cognitive-behavioral talk therapy, and Zoloft (or sertraline), an antidepressant medication. PTSD is characterized by difficulties such as nightmares, anxiety, and upsetting memories that persist for at least one month after a traumatic event (such as physical or sexual assault, or a serious accident). Eligible participants will be offered at least ten weeks of treatment at no cost. Participants will be interviewed at the end of treatment and at three, six, twelve, and twenty-four months after receiving treatment. There is no cost to participate and compensation will be provided for the follow-up interviews. |
| Criteria: |
Participants must be between the ages of 18 and 65 and meet the study criteria for chronic PTSD. To be eligible for this study, it must be at least 12 weeks since the traumatic event. |
| Contact: |
For information or to register for screening in this trial please call HealthMatch at (216) 844-5000, or complete and submit the form below. |
Participant Confidentiality:
All information regarding participation in Clinical Trials is treated with the
utmost confidentiality. University Hospitals Case Medical Center and the
Division of Clinical Research recognize and respect the confidentiality of this
information. Access to information related to clinical trials and their
participants is restricted to authorized clinical trials personnel only.
Back